Unfolding the biosimilar landscape in Latin America PMLiVE An example of this is the early access by as the company Probiomed with their biosimilar rituximab, Kikuzubam, which was obtained just before this regulation was in place. By contrast, successful entry and establishment of biosimilars in the Argentine ... |
